BD to Present at Investor Virtual Healthcare Conferences
Get Alerts BDX Hot Sheet
Join SI Premium – FREE
FRANKLIN LAKES, N.J., Nov. 9, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following upcoming virtual healthcare conferences:
Stifel 2020 Virtual Healthcare ConferenceNovember 16, 20209:20 a.m. EDT
Jefferies Virtual London Healthcare ConferenceNovember 18, 20207:55 a.m. EDT
Live webcasts of BD's presentations can be accessed on the BD corporate website at www.bd.com/investors. A replay will be available for a minimum of seven days after each conference.
About BDBD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.
Contact:
Kristen M. Stewart, CFA, Strategy & Investor Relations - 201-847-5378Kristen Cardillo, Communications - 201-847-5657
View original content:http://www.prnewswire.com/news-releases/bd-to-present-at-investor-virtual-healthcare-conferences-301169057.html
SOURCE BD (Becton, Dickinson and Company)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sunshine Guojian Releases 2026 Interim Report:
- Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 49th Parallel Wealth Management Closes Out a Summer of Cross-Border Innovation -- Free Tools, an Audiobook, and a New App, With a Hardcover Edition on the Way
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Stifel, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share